3.0.0 6238 2022-02-08T23:17:31Z 2022-02-08T23:17:31Z House HR 2020-03-12 116 [Congressional Record Volume 166, Number 48 (Thursday, March 12, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. GOTTHEIMER:H.R. 6238.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 18: To make all laws thatshall be necessary and proper for carrying into execution theforegoing powers, and all powers vested by this Constitutionin the government of the United State, or in any departmentor officer thereof.[Page H1670]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-03-12T13:01:40Z hswm00 Ways and Means Committee House Standing Referred to 2020-03-12T13:01:35Z 2020-03-12 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-03-12 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2020-03-12 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-03-12 Introduced in House IntroReferral 1000 9 Library of Congress G000583 Rep. Gottheimer, Josh [D-NJ-5] Josh Gottheimer D NJ 5 N U000031 Rep. Upton, Fred [R-MI-6] FRED UPTON R MI 6 2020-03-12 True Taxation Business expenses Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Government studies and investigations Income tax credits Medical research Medical tests and diagnostic methods Research and development Taxation 00 2020-03-12 Introduced in House 2020-04-01T12:46:03Z Cameron's Law

This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit).

The bill also requires the Centers for Disease Control and Prevention to complete a study and report on enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.

]]> Cameron’s Law Display Title Cameron’s Law Official Title as Introduced To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit, and for other purposes. Introduced in House IH Short Title(s) as Introduced Cameron’s Law Introduced in House IH Introduced in House 2020-03-12T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr6238ih/xml/BILLS-116hr6238ih.xml 2020-03-12 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.